Description

Description

Neoglip 50/850mg is a combination tablet manufactured by ATCO Laboratories, containing two active ingredients: Sitagliptin and Metformin. Sitagliptin belongs to a class of medicines called DPP-4 inhibitors that help the body increase insulin release after meals, while Metformin works by reducing the amount of sugar produced by the liver and improving the body’s response to insulin. Together, these two components help manage blood sugar levels through complementary mechanisms. Each pack contains 14 tablets. Neoglip is available only with a valid prescription and should be used under proper medical supervision as part of an overall diabetes management plan.

Ingredients

Each Neoglip tablet contains Sitagliptin 50mg and Metformin 850mg as active ingredients, along with standard pharmaceutical excipients that support tablet formation, stability, and absorption. The formulation follows the quality standards maintained by ATCO Laboratories.

Dosage Form

Neoglip is available as an oral tablet, combining 50mg of Sitagliptin and 850mg of Metformin per tablet, supplied in a pack of 14 tablets.

Uses

Neoglip is prescribed for the management of type 2 diabetes in adults, typically when blood sugar is not adequately controlled by diet, exercise, and a single medication alone. It is generally used for patients who require the combined action of both a DPP-4 inhibitor and Metformin to achieve better glycemic control. This medicine is not intended for type 1 diabetes or diabetic ketoacidosis. The suitability of this combination for a particular patient should always be determined by a qualified healthcare provider.

How to Use

Neoglip should be taken exactly as prescribed by your doctor, usually with meals to help reduce digestive side effects associated with Metformin. Swallow the tablet whole with a glass of water; do not crush or chew it. Blood sugar levels should be monitored regularly during treatment, and the dose should not be adjusted without medical advice. This medicine works best when combined with a consistent diet and exercise routine as recommended by your doctor.

Side Effects

Common side effects of Neoglip include nausea, diarrhea, stomach discomfort, and reduced appetite, particularly when treatment begins. Some individuals may experience headache or upper respiratory symptoms. Less commonly, this medicine may contribute to a rare but serious condition called lactic acidosis, especially in individuals with kidney or liver problems, so warning signs such as unusual muscle pain, difficulty breathing, or extreme tiredness should be reported to a doctor immediately. Low blood sugar (hypoglycemia) may occur, particularly if used alongside other diabetes medicines.

Pregnancy & Breastfeeding

Neoglip should only be used during pregnancy or breastfeeding if specifically advised by a doctor, as blood sugar management needs often change during these periods and alternative treatments may be preferred. Women who are pregnant, planning pregnancy, or breastfeeding should discuss their diabetes management plan with their healthcare provider.

Storage Instructions

Store Neoglip tablets at room temperature, away from direct sunlight, heat, and moisture. Keep the medicine in its original packaging, tightly closed, and out of reach of children. Do not use tablets beyond their printed expiry date.

FAQs

Is Neoglip available without a prescription? No, Neoglip is a prescription-only medicine and should not be used without medical advice.

Why does Neoglip combine two medicines? It combines a DPP-4 inhibitor and Metformin to control blood sugar more effectively than either medicine may achieve alone.

How many tablets are in one pack? Each pack of Neoglip contains 14 tablets.

Who manufactures Neoglip? Neoglip is manufactured by ATCO Laboratories.

Should Neoglip be taken with food? Yes, it is generally recommended to take it with meals to reduce the chance of stomach upset.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.